23.100
+14,93%
2026-10-15
Fundamental Analysis
85 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +324.4% | +120.5% | 3 / 3 | -3.3% | +0.22 pp | +536.19 pp | +31.7% | 0.00 | 5.92 | 35,8 | −3,3% | 249 | +324,4% | 5.92 | 34.02 | −82,6% |
| Pts | 12 | 12 | 12 | 0 | 8 | 12 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 23.100 (close price on 2026-10-15)EPS (TTM): 3.904
Financial charts
1.Revenue & growth
VND bn35,8Q2/26
1.Revenue & growth
VND bn35,8Q2/26
2.Profit & growth
VND bn249Q2/26
3.Profit mix (Penman)
VND bn349Q2/26
4.Margins & cost structure
%28.1%Q2/26
5.Returns & cash cycle
% · days6.7%Q2/26
6.Earnings quality & cash
VND bn4,76Q2/26
7.Asset structure
VND bn1.222Q2/26
8.Funding & debt health
VND bn · times1.222Q2/26
9.Revenue backlog
VND bn8,45Q2/26
10.Valuation
times · %5,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %3.326Q2/26
Adjusted EPS growth, latest quarter
324%
Average adjusted EPS growth, 3 quarters
120%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26